PPT-B-cell responses to 13-valent pneumococcal conjugate vaccine in patients with severe chronic
Author : elitered | Published Date : 2020-08-03
Gabrielle Gaultier PhD Biotechnology Candidate Lakehead University Supervisor Dr Marina Ulanova Northern Health Research Conference 2017 1 Faculty Presenter
Presentation Embed Code
Download Presentation
Download Presentation The PPT/PDF document "B-cell responses to 13-valent pneumococc..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
B-cell responses to 13-valent pneumococcal conjugate vaccine in patients with severe chronic: Transcript
Gabrielle Gaultier PhD Biotechnology Candidate Lakehead University Supervisor Dr Marina Ulanova Northern Health Research Conference 2017 1 Faculty Presenter Disclosure Slide 2. New generation typhoid conjugate vaccinefor preventing typhoid diseaseTEAM BHARAT This disease is common in many developing countries of Africa, Asia,The Middle East, The Caribbean, Central and South Public . health doctor . specializing . in respiratory . disease. Centers for Disease Control and Prevention . Pneumococcal Pneumonia and Pandemic H1N1. Emerging Infectious Diseases. National Center for Emerging and . Distributed Computing. Lecture . 12. Distributed Consensus. Hwajung Lee. Distributed Consensus. Reaching agreement is a fundamental problem in distributed . computing. . Some examples are. Leader election / Mutual Exclusion. Claire Bowe Registered Nurse, Non Medical Prescriber . A vaccine is a biological preparation that improves immunity to a particular disease (WHO, 2016). . Vaccines employ innocuous forms of the disease agent, usually from a killed or weakened bacteria or virus, which stimulate antibody production.. BMJ Learning. د. حسين محمد جمعة . اختصاصي الامراض الباطنة . البورد العربي . كلية طب الموصل . 2010. Asthma. Centro de Biotecnologia. giovana.barazzone. @butantan.gov.br. Pneumococcal conjugate vaccine – Use of pneumococcal surface protein A (PspA) as carrier . 1. Streptococcus pneumoniae. Streptococcus pneumoniae. Dr. Soheila . zareifar. Department of pediatric hematology/oncology. Shiraz university of medical sciences. Qeshm. 2018. Transfusion in Sickle Cell. In sickle cell disease transfusions improve blood flow by reducing the proportion of red cells capable of forming sickle hemoglobin polymer. . An Advisory Committee Statement ACSNational Advisory Committee on Immunization NACIUpdate on the use of 13valent pneumococcal conjugate vaccine PNEU13 in addition to 23valent pneumococcal polysacchari killed OPVoral poliovirus vaccine live HibHaemophilus influenzaetype b conjugate vaccine MenACWYquadravalent meningococcal conjugate vaccine PCVpneumococcal conjugate vaccine PPSVpneumococcal polysacc David H. Spach, MD. Professor of Medicine, Division of Infectious Diseases . University of Washington. Seattle, . Washington. Financial Relationships With Commercial Entities. Dr. Spach has no financial relationships with commercial entities to disclose. (Updated 05/17/21). 3 Recombivax HB (refer to Hep B-Hib) Combination vaccine: Hep B-Hib Haemophilus influenzae type b and inactivated poliovirus HBIG** Hepatitis B Immune Globulin (given to newborns or children with p Casadevall A. Antibody-Based Therapies for Emerging Infectious Diseases. Emerg Infect Dis. 1996;2(3):200-208. https://doi.org/10.3201/eid0203.960306. Houseman C, Hughes GJ, Chapman KE, Wilson D, Gorton R. Increased Invasive Pneumococcal Disease, North East England, UK. Emerg Infect Dis. 2017;23(1):122-126. https://doi.org/10.3201/eid2301.160897. Fiore AE, Levine OS, Elliott JA, Facklam RR, Butler JC. Effectiveness of Pneumococcal Polysaccharide Vaccine for Preschool-Age Children with Chronic Disease. Emerg Infect Dis. 1999;5(6):828-831. https://doi.org/10.3201/eid0506.990616.
Download Document
Here is the link to download the presentation.
"B-cell responses to 13-valent pneumococcal conjugate vaccine in patients with severe chronic"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.
Related Documents
